Inspira Technologies to Showcase INSPIRA ART100 at AmSECT 63rd International Conference in San Diego

Inspira Technologies to Showcase Life-Support Innovation at AmSECT Conference

In a significant leap for medical technology, Inspira Technologies OXY B.H.N. Ltd. has announced its participation in the upcoming AmSECT 63rd International Conference, taking place from March 19-23, 2025, at the Loews Coronado Bay Resort in San Diego, California. This premier event for perfusion professionals will serve as a platform for Inspira to unveil its INSPIRA ART100, an FDA-cleared life-support system that revolutionizes cardiopulmonary bypass procedures.

The INSPIRA ART100 represents a groundbreaking stride in extracorporeal circulation technology, which is vital for patients undergoing cardiac operations. This life-support system had previously received FDA 510(k) clearance in May 2024, marking it as a reliable option for medical professionals involved in high-stakes procedures requiring advanced respiratory support.

Dagi Ben-Noon, the CEO of Inspira Technologies, expressed enthusiasm for the conference, stating, "The AmSECT International Conference brings together leading perfusion professionals, providing an ideal platform to showcase our INSPIRA ART100 system. This event is a fantastic opportunity to further expose our innovative technology to the perfusion community. We look forward to connecting with industry experts and demonstrating how our solutions can support medical professionals."

Attendees will have the unique opportunity to engage with Inspira’s technology at the Glo-Med Networks booth, the company responsible for distributing the INSPIRA ART100. The hands-on experience will allow professionals to see first-hand how the system operates and its potential to improve patient outcomes during surgical procedures.

The AmSECT conference is renowned for its focus on advancements in perfusion technology, patient care, and education. This gathering not only attracts technical experts but also fosters discussions on the latest research and technologies that shape the future of perfusion practices. The INSPIRA ART100, with its advanced capabilities, is expected to be a focal point of interest for all delegated attending this event.

Inspira Technologies is at the forefront of developing innovative respiratory support and diagnostic solutions. The company aims to transform the landscape of critical care with products designed to enhance patient comfort and improve clinical outcomes. In addition to the INSPIRA ART100, the flagship INSPIRA ART500 system is currently under development, designed to allow patients to stay awake and maintain stable oxygen levels without mechanical ventilation, showcasing the company’s commitment to innovation in patient care.

Furthermore, the company has developed the HYLA blood sensor, a state-of-the-art technology aiming to provide continuous, real-time blood monitoring without the need for frequent blood draws—demonstrating Inspira’s relentless pursuit of enhancing healthcare delivery through technology.

To schedule a meeting during the conference, interested parties are encouraged to reach out to Mr. Levi Perryman at [email protected] or visit Booth number 4 during the event.

About Inspira Technologies

Founded in Israel, Inspira Technologies is committed to innovation in the medical technology sector, primarily focusing on life-support systems that are both efficient and patient-friendly. The company’s products not only seek to streamline clinical processes but also aim to enhance the overall patient experience within critical care environments. By pushing the boundaries of what is possible in ventilatory support, Inspira Technologies is poised to play a critical role in the future of healthcare.

For more details about their products and innovations, visit Inspira Technologies.